<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu Z</submitter><funding>Foundation of National Facility for Translational Medicine</funding><funding>Foundation of National Facility for Translational Medicine (Shanghai)</funding><funding>Postdoctoral Research Foundation of China</funding><funding>National Natural Science Foundation of China</funding><funding>Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support</funding><funding>Shanghai Anticancer Association Eyas Project</funding><funding>Shanghai Sailing Program</funding><pagination>170</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8973627</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>Contrast-enhanced MR angiography (MRA) is a critical technique for vascular imaging. Nevertheless, the efficacy of MRA is often limited by the low rate of relaxation, short blood-circulation time, and metal ion-released potential long-term toxicity of clinical available Gd-based contrast agents. In this work, we report a facile and efficient strategy to achieve Gd-chelated organic nanoparticles with high relaxivity for T&lt;sub>1&lt;/sub>-weighted MRA imaging. The Gd-chelated PEG-TCPP nanoparticles (GPT NPs) have been engineered composite structured consisting of Gd-chelated TCPP and PEG. The spherical structure of TCPP offers more chemical sites for Gd&lt;sup>3+&lt;/sup> coordination to improve the relaxivity and avoid leakage of the Gd&lt;sup>3+&lt;/sup> ions. The synthesized GPT NPs exhibit a high relaxation rate of 35.76 mM&lt;sup>- 1&lt;/sup> s&lt;sup>- 1&lt;/sup> at 3.0 T, which is higher than the rates for most reported MR contrast agents. Therefore, GPT NPs can be used for MRA with much stronger vascular signals, longer circulation time, and high-resolution arterial vascular visualization than those using clinical MR contrast agents at the same dose. This work may make the T&lt;sub>1&lt;/sub> MRI contrast agents for high-resolution angiography possible and offer a new candidate for preclinical and clinical applications of MR vascular imaging and vascular disease diagnosis.</pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>High relaxivity Gd&lt;sup>3+&lt;/sup>-based organic nanoparticles for efficient magnetic resonance angiography.</pubmed_title><pmcid>PMC8973627</pmcid><funding_grant_id>SACA-CY19A04</funding_grant_id><funding_grant_id>TMSK-2021-122</funding_grant_id><funding_grant_id>19YF1410100</funding_grant_id><funding_grant_id>21YF1411500</funding_grant_id><funding_grant_id>82102190</funding_grant_id><funding_grant_id>2020M681326</funding_grant_id><funding_grant_id>20191805</funding_grant_id><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Peng W</pubmed_authors><pubmed_authors>Gu Y</pubmed_authors><pubmed_authors>Fu Z</pubmed_authors><pubmed_authors>Ni D</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Gao H</pubmed_authors><pubmed_authors>Tang W</pubmed_authors></additional><is_claimable>false</is_claimable><name>High relaxivity Gd&lt;sup>3+&lt;/sup>-based organic nanoparticles for efficient magnetic resonance angiography.</name><description>Contrast-enhanced MR angiography (MRA) is a critical technique for vascular imaging. Nevertheless, the efficacy of MRA is often limited by the low rate of relaxation, short blood-circulation time, and metal ion-released potential long-term toxicity of clinical available Gd-based contrast agents. In this work, we report a facile and efficient strategy to achieve Gd-chelated organic nanoparticles with high relaxivity for T&lt;sub>1&lt;/sub>-weighted MRA imaging. The Gd-chelated PEG-TCPP nanoparticles (GPT NPs) have been engineered composite structured consisting of Gd-chelated TCPP and PEG. The spherical structure of TCPP offers more chemical sites for Gd&lt;sup>3+&lt;/sup> coordination to improve the relaxivity and avoid leakage of the Gd&lt;sup>3+&lt;/sup> ions. The synthesized GPT NPs exhibit a high relaxation rate of 35.76 mM&lt;sup>- 1&lt;/sup> s&lt;sup>- 1&lt;/sup> at 3.0 T, which is higher than the rates for most reported MR contrast agents. Therefore, GPT NPs can be used for MRA with much stronger vascular signals, longer circulation time, and high-resolution arterial vascular visualization than those using clinical MR contrast agents at the same dose. This work may make the T&lt;sub>1&lt;/sub> MRI contrast agents for high-resolution angiography possible and offer a new candidate for preclinical and clinical applications of MR vascular imaging and vascular disease diagnosis.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T08:24:39.889Z</modification><creation>2025-04-04T08:24:39.889Z</creation></dates><accession>S-EPMC8973627</accession><cross_references><pubmed>35361219</pubmed><doi>10.1186/s12951-022-01363-3</doi></cross_references></HashMap>